MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/acn3.50873

Медицинская библиотека · Annals of clinical and translational neurology · 2019

Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse.

Alcolea Daniel, Pegueroles Jordi, Muñoz Laia, Camacho Valle, López-Mora Diego, Fernández-León Alejandro, Le Bastard Nathalie, Huyck Els, Nadal Alicia, Olmedo Verónica, Sampedro Frederic, Montal Victor, Vilaplana Eduard, Clarimón Jordi, Blesa Rafael, Fortea Juan, Lleó Alberto

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To determine the cutoffs that optimized the agreement between 18 F-Florbetapir positron emission tomography (PET) and Aβ1-42, Aβ1-40, tTau, pTau and their ratios measured in cerebrospinal fluid (CSF) on the LUMIPULSE G600II instrument, we quantified the levels of these four biomarkers in 94 CSF samples from participants of the Sant Pau Initiative on Neurodegeneration (SPIN cohort) using the Lumipulse G System with available 18 F-Florbetapir imaging.

METHODS

Participants had mild cognitive impairment (n = 35), AD dementia (n = 12), other dementias or neurodegenerative diseases (n = 41), or were cognitively normal controls (n = 6). Levels of Aβ1-42 were standardized to certified reference material. Amyloid scans were assessed visually and through automated quantification. We determined the cutoffs of CSF biomarkers that optimized their agreement with 18 F-Florbetapir PET and evaluated concordance between markers of the amyloid category.

RESULTS

Aβ1-42, tTau and pTau (but not Aβ1-40) and the ratios with Aβ1-42 had good diagnostic agreement with 18 F-Florbetapir PET. As a marker of amyloid pathology, the Aβ1-42/Aβ1-40 ratio had higher agreement and better correlation with amyloid PET than Aβ1-42 alone.

INTERPRETATION: CSF biomarkers measured with the Lumipulse G System show good agreement with amyloid imaging in a clinical setting with heterogeneous presentations of neurological disorders. Combination of Aβ1-42 with Aβ1-40 increases the agreement between markers of amyloid pathology.

Для цитирования: Alcolea Daniel, Pegueroles Jordi, Muñoz Laia, Camacho Valle, López-Mora Diego, Fernández-León Alejandro, Le Bastard Nathalie, Huyck Els, Nadal Alicia, Olmedo Verónica, Sampedro Frederic, Montal Victor, Vilaplana Eduard, Clarimón Jordi, Blesa Rafael, Fortea Juan, Lleó Alberto. Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse.. Annals of clinical and translational neurology. 2019. DOI: 10.1002/acn3.50873.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.